Papazoglou, Anna
Henseler, Christina
Weickhardt, Sandra
Daubner, Johanna
Schiffer, Teresa
Broich, Karl
Hescheler, Jürgen
Sachinidis, Agapios
Ehninger, Dan
Haenisch, Britta
Weiergräber, Marco
Funding for this research was provided by:
Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM)
Article History
Received: 14 September 2023
Accepted: 7 May 2024
First Online: 21 May 2024
Declarations
:
: All animal procedures were carried out in accordance with the Guidelines of the German Council on Animal Care and all protocols were approved by the Local Institutional and National Committee on Animal Care (Landesamt für Natur, Umwelt und Verbraucherschutz, LANUV, Germany). The authors further certify that all animal experimentation complied with the ARRIVE guidelines and were carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines; EU Directive 2010/63/EU for animal experiments; or the National Institutes of Health guide for the care and use of laboratory animals (NIH Publications No. 8023, revised 1978). Maximum effort was made to reduce the number of animals necessary to obtain data and suffering of the animals according to the 3R strategy.
: Not applicable.
: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.